CLINICAL TRIAL OF MEDROXYPROGESTRONE ACETATE ON MENSTUREAL BLOOD LOSS AND QUALITYOF LIFE IN WOMEN WITH MENORRHAGIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOUKHAH SOMAYEH; GOSHTASEBI AZITA; MOAYED MOHSENI SAKINEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: DANESHVAR MEDICINE Year:2011 | Volume:18 | Issue:93 Page(s): 21-32

Download Full-Text

Persian Verion

View:

4,547

Download:

Cites:

Information Journal Paper

Title

CLINICAL TRIAL OF MEDROXYPROGESTRONE ACETATE ON MENSTUREAL BLOOD LOSS AND QUALITYOF LIFE IN WOMEN WITH MENORRHAGIA

Author(s)

MOUKHAH SOMAYEH | GOSHTASEBI AZITA | MOAYED MOHSENI SAKINEH | Issue Writer Certificate

Keywords

MEDROXYPROGESTRONE ACETETQ3

MMENORRHAGIAQ2

QUALITY OF LIFEQ2

HIGHAM CHARTQ2

Abstract

Background and Objective: Severe menstrual bleeding is a leading cause of poor QUALITY OF LIFE and iron deficiency anemia in reproductive aged women. The aim of this study was to investigate the efficacy and acceptability of long-term use of medroxyprogestrone acetate in menorrhagia management.Materials and Methods: In a pre-post trial, 44 eligible women were allocated to long term medroxyprogestrone acetate treatment (for 3 consecutive cycles). Changes in duration and amount of bleeding, QUALITY OF LIFE and also hemoglobin and ferritin values were checked out and compared before and after treatment.Results: Medroxyprogestrone acetate reduced mean PBLAC score from 220.15 (±74.99) in control cycle to 108.81 (±74.98) in third cycle (p<0.0001). Hemoglobin increased from 12.24 (±0.89) to 13.21 (±0.88) g/dl and ferritin increased from 13.38 (±6.81) to 30.85 (±8.51) ng/dl (p<0/0001). Duration of menstrual bleeding decreased from 8.4 (±1.47) days to 8.06 (±1.53) days (p=0.001). Medroxyprogestrone acetate reduced mean MQ score from 66.46 (±13.82) to 14.13 (±7.98) (p<0.0001). SF-36 QUALITY OF LIFE scores increased in all aspects (except for bodily pain) (p<0.0001).Conclusion: Our results showed that long term use of MPA is an effective treatment for idiopathic menorrhagia in terms of menstrual blood loss, hematologic indices and QUALITY OF LIFE (p<0.05) and observed complications are not significant. This makes long-term MPA a favored drug choice in idiopathic menorrhagia management in premenopausal women.

Cites

Effect of hydro alcoholic extract of Achillea Millefolium on menorrhagia

References

No record.

Cite

APA: Copy

MOUKHAH, SOMAYEH, GOSHTASEBI, AZITA, & MOAYED MOHSENI, SAKINEH. (2011). CLINICAL TRIAL OF MEDROXYPROGESTRONE ACETATE ON MENSTUREAL BLOOD LOSS AND QUALITYOF LIFE IN WOMEN WITH MENORRHAGIA. DANESHVAR MEDICINE, 18(93), 21-32. SID. https://sid.ir/paper/30717/en

Vancouver: Copy

MOUKHAH SOMAYEH, GOSHTASEBI AZITA, MOAYED MOHSENI SAKINEH. CLINICAL TRIAL OF MEDROXYPROGESTRONE ACETATE ON MENSTUREAL BLOOD LOSS AND QUALITYOF LIFE IN WOMEN WITH MENORRHAGIA. DANESHVAR MEDICINE[Internet]. 2011;18(93):21-32. Available from: https://sid.ir/paper/30717/en

IEEE: Copy

SOMAYEH MOUKHAH, AZITA GOSHTASEBI, and SAKINEH MOAYED MOHSENI, “CLINICAL TRIAL OF MEDROXYPROGESTRONE ACETATE ON MENSTUREAL BLOOD LOSS AND QUALITYOF LIFE IN WOMEN WITH MENORRHAGIA,” DANESHVAR MEDICINE, vol. 18, no. 93, pp. 21–32, 2011, [Online]. Available: https://sid.ir/paper/30717/en

Related Journal Papers